MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Whole-Exome Sequencing in a Movement Disorders Clinic

    C. Shah, L. Robak, E. Hill, J. Jankovic (Houston, USA)

    Objective: To evaluate the diagnostic utility of whole-exome sequencing (WES) in select patients with a movement disorder. Background: Many patients with suspected genetic movement disorders…
  • MDS Virtual Congress 2021

    Using Human Neural Tissue Methylation to Decipher Epigenetic Characteristics and Cell Type Pathologies in Huntington’s Disease

    A. Glaser, J. Levy, Z. Zhang, L. Salas (Hanover, USA)

    Objective: This study combines methylation data from the two largest EWAS studies in Huntington's Disease (HD) human brain tissue [1,2]. Combined, this study yields the…
  • MDS Virtual Congress 2021

    Characterizing US Healthcare Delivery in Huntington’s Disease (HD)

    L. Seeberger, J. Corey-Bloom, M. O'Brien, P. Chen, B. Griffin, D. Schlang, D. Slowiejko (Aurora, USA)

    Objective: The HD-Net research survey aimed to assess care patterns among practice types in the U.S., to identify gaps in the provision of HD care.…
  • MDS Virtual Congress 2021

    SARS-CoV-2 Encephalopathy Presenting as Opsoclonus Myoclonus Syndrome Successfully Treated with IV Immunoglobulins

    M. Salgado, I. Hacker, A. Alport, J. Ma (Brooklyn, USA)

    Objective: To present a case of a SARS-CoV-2 patient presenting with opsoclonus myoclonus syndrome who was successfully treated with IVIGs. Background: The COVID-19 pandemic has…
  • MDS Virtual Congress 2021

    Distinct patterns of dyskinetic and dystonic features following D1 or D2 receptor stimulation in a mouse model of parkinsonism

    L. Andreoli, M. Abbaszadeh, X. Cao, A. Cenci Nilsson (Lund, Sweden)

    Objective: We set out to compare patterns of dyskinetic behaviours induced by the systemic administration of L-DOPA and D1 or D2 receptor (D1R, D2R) agonists…
  • MDS Virtual Congress 2021

    Can event-related oscillations aid in differentiating Parkinson’s disease and dementia with Lewy bodies?

    Y. Rosenblum, T. Shiner, N. Bregman, I. Maidan, F. Fahoum, N. Giladi, A. Mirelman (Tel Aviv, Israel)

    Objective: To assess the specificity of an EEG signature of the visual event-related oscillations (ERO) in synucleinopathies. Background: Parkinson's disease (PD), PD dementia (PDD) and…
  • MDS Virtual Congress 2021

    Neuroleptic Malignant Syndrome: Case Series of Movement Disorders Emergency

    IAH. Hakim, NR. Raisa, WMS. Santoso, CAS. Setianto (Malang, Indonesia)

    Objective: We describe four cases of Neuroleptic Malignant Syndrome (NMS) with high mortality rates, despite decreased reports of the disease in the past decades. Background:…
  • MDS Virtual Congress 2021

    EFFECT OF TRANSCRANIAL DIRECT CURRENT STIMULATION (tDCS) ON LOCOMOTOR FUNCTION IN PATIENTS WITH PARKINSON’S DISEASE

    M. Shah, B. Bajaj, I. Ali (New Delhi, India)

    Objective: Objectives Primary objective: To determine the effect of bilateral anodal transcranial direct current stimulation (tDCS) on locomotor function in patients with Parkinson’s disease immediately…
  • MDS Virtual Congress 2021

    Disparities in Access to Spasticity Chemodenervation Specialists in the United States: a National Analysis of Medicare Data

    R. Kazerooni, S. Healy, M. Verduzco-Gutierrez (Raleigh, USA)

    Objective: To explore the variations in access to spasticity chemodenervation specialists across several geographical, ethnic, racial, and population density factors. Background: Equity in access to…
  • MDS Virtual Congress 2021

    Modeling of the Placebo Response in Parkinson’s Disease

    S. Branders, O. Rascol, G. Garraux, B. Berman, G. Stebbins, C. Goetz, C. Billocq, A. Pereira (Mont-Saint-Guibert, Belgium)

    Objective: The objective of this study was to investigate the predictability of the placebo response in Parkinson's disease (PD) subjects participating in a randomized clinical…
  • « Previous Page
  • 1
  • …
  • 66
  • 67
  • 68
  • 69
  • 70
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #25116 (not found)
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley